Maridose, a leading provider of cannabis for research located in Brunswick, Maine, proudly announces the opening of a Center of Excellence for Cannabis Research. This new establishment will enhance their current research capabilities and allow them to cultivate high-quality cannabis for DEA-approved studies, with the goal of commercializing prescription and non-prescription drugs, as well as dietary supplements.
Founder Richard Shain expressed his gratitude for the support from the State of Maine and MRRA, the operator of Brunswick Landing. Maridose recognizes the advantages of being located at TechPlace, Brunswick Landing’s innovation center, which provides access to a collaborative environment fostering innovation and cutting-edge technologies.
Funding for this expansion project is currently underway through a private placement managed by Young America Capital. This collaboration will help ensure that the Center of Excellence for Cannabis Research becomes a reality.
Maridose is a leading biopharmaceutical research and product development company focused on cannabis and cannabis-derived products. The company was selected by the U.S. DOJ and DEA to legally cultivate and sell cannabis at its Center of Excellence in Brunswick Landing, Maine, providing best-in-class cannabis cultivation, research and product development.
TechPlace at Brunswick Landing is an innovation hub fostering collaboration and cutting-edge research. This dynamic ecosystem provides Maridose with state-of-the-art facilities and a vibrant community, positioning the company at the forefront of cannabis research. For more information, visit the TechPlace Brunswick Landing website.
In conclusion, Maridose and TechPlace at Brunswick Landing are proud to be at the forefront of cannabis research, and they look forward to contributing to the growth of Maine’s biotech community and the broader research industry. For more information, please visit the official Maridose website.
SOURCE: Husbands LLC
Source link
